Global burden of brain disorders surpasses cardiovascular disease and cancerJuly 12, 2023Alzheimer's & CognitionStrokeHeadache & MigraineEpilepsy & SeizuresMultiple SclerosisParkinson's Disease
MS relapse rates similar between anti-CD20 mAbs and switching to fumaratesJune 9, 2023Multiple Sclerosis
Ozanimod for relapsing MS shows long-term safety, efficacy with age differencesJune 8, 2023Multiple Sclerosis
Multiple changes in NMOSD treatment for nonmedical reasons tied to poorer outcomesJune 6, 2023Multiple Sclerosis
Racial, ethnic disparities persist in access to MS careJune 6, 2023Multiple SclerosisDiversity in Medicine